These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9137973)

  • 1. Experimental plasmacytomagenesis in mice.
    Potter M
    Hematol Oncol Clin North Am; 1997 Apr; 11(2):323-47. PubMed ID: 9137973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice.
    Hilbert DM; Pumphrey JG; Troppmair J; Rapp UR; Rudikoff S
    Oncogene; 1993 Jul; 8(7):1993-2000. PubMed ID: 7685514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse plasmacytoma: an experimental model of human multiple myeloma.
    Gadó K; Silva S; Pálóczi K; Domján G; Falus A
    Haematologica; 2001 Mar; 86(3):227-36. PubMed ID: 11255268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
    Potter M; Wiener F
    Carcinogenesis; 1992 Oct; 13(10):1681-97. PubMed ID: 1423827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the origins of multiple myeloma and plasmacytomas in mice.
    Potter M
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):211-23. PubMed ID: 1582969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice.
    Coleman AE; Ried T; Janz S
    Genes Chromosomes Cancer; 2000 Sep; 29(1):70-4. PubMed ID: 10918396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental animal models of multiple myeloma].
    Miyakawa Y
    Nihon Rinsho; 2007 Dec; 65(12):2211-7. PubMed ID: 18069262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma biology: lessons from the 5TMM models.
    Vanderkerken K; Asosingh K; Croucher P; Van Camp B
    Immunol Rev; 2003 Aug; 194():196-206. PubMed ID: 12846816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS; Han SS; Park SS; McNeil N; Janz S
    J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.
    Amoroso SR; Huang N; Roberts AB; Potter M; Letterio JJ
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):189-94. PubMed ID: 9419351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transgenic mouse model of plasma cell malignancy shows phenotypic, cytogenetic, and gene expression heterogeneity similar to human multiple myeloma.
    Boylan KL; Gosse MA; Staggs SE; Janz S; Grindle S; Kansas GS; Van Ness BG
    Cancer Res; 2007 May; 67(9):4069-78. PubMed ID: 17483317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
    Wiener F; Coleman A; Mock BA; Potter M
    Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoplastic development in plasma cells.
    Potter M
    Immunol Rev; 2003 Aug; 194():177-95. PubMed ID: 12846815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory mechanisms in multiple myeloma.
    Munshi NC
    Hematol Oncol Clin North Am; 1997 Feb; 11(1):51-69. PubMed ID: 9081204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an orthotopic SCID mouse-human tumor xenograft model displaying the multidrug-resistant phenotype.
    Bellamy WT; Mendibles P; Bontje P; Thompson F; Richter L; Weinstein RS; Grogan TM
    Cancer Chemother Pharmacol; 1996; 37(4):305-16. PubMed ID: 8548875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
    Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
    Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of oncogenesis and progression in human myeloma].
    Kawano MM; Otsuyama K
    Nihon Rinsho; 2007 Dec; 65(12):2187-93. PubMed ID: 18069259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New experimental model of multiple myeloma.
    Telegin GB; Kalinina AR; Ponomarenko NA; Ovsepyan AA; Smirnov SV; Tsybenko VV; Homeriki SG
    Bull Exp Biol Med; 2001 Jun; 131(6):609-12. PubMed ID: 11586419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.